Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06986161 · ClinicalTrials.gov registry record · NA

Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals

A NA study of Pre Diabetes, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06986161 is a NA study of Pre Diabetes that is actively recruiting participants, run by Clinical Nutrition Research Center, Illinois Institute of Technology. The registered enrollment target is 30 participants, below the 729-participant average among 59 other Pre Diabetes trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06986161, a NA study of Pre Diabetes, is actively recruiting participants, sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to investigate the effect of mango intake on metabolic and inflammatory responses relative to meals in individuals at risk of developing diabetes, as well as to understand how the beneficial compounds found in mangoes are absorbed and processed in the body.

Conditions Studied

Interventions

  • OTHER Mango
  • OTHER Control Beverage

Study Locations (1)

Illinois

  • Clinical Nutrition Research Center - Chicago

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-04-14
Est. Completion 2026-12-31
Phase NA

What the Registry Record Tells You About NCT06986161

The ClinicalTrials.gov registry entry for NCT06986161 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 729-participant average among 59 other Pre Diabetes trials with a reported enrollment target (96% lower). The listed sponsor is Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pre Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Mango is the first listed.

NCT06986161 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06986161 about?

NCT06986161 is a clinical study titled "Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals". The purpose of this study is to investigate the effect of mango intake on metabolic and inflammatory responses relative to meals in individuals at risk of developing diabetes, as well as to understand how the beneficial compounds found in mangoes are absorbed and processed in the body.

What is the current status of trial NCT06986161?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-04-14. Estimated completion is 2026-12-31.

What conditions does trial NCT06986161 study?

This clinical trial studies the following conditions: Pre Diabetes.

What interventions are being tested in trial NCT06986161?

The interventions under investigation include: Mango (OTHER), Control Beverage (OTHER).

Who is sponsoring clinical trial NCT06986161?

This trial is sponsored by Clinical Nutrition Research Center, Illinois Institute of Technology, which has 59 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06986161 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pre Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.